Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C5344 HET0016Summary: inhibitor of 20-HETE formation -
C5346 MJ33 (lithium salt)Summary: inhibitor of the acidic, calcium-independent (ai)PLA2 activity of Prdx6 -
C5414 TPPUTarget: epoxide hydrolaseSummary: potent inhibitor of both human and mouse sEH -
C5619 N-BenzylpalmitamideSummary: inhibitor of fatty acid amide hydrolase (FAAH) -
C5631 Glycerophospho-N-Oleoyl EthanolamineSummary: precursor of oleoyl ethanolamide (OEA) -
C5603 A-771726Summary: dihydroorotate dehydrogenase inhibitor -
C5712 DG-172 (hydrochloride)Summary: orally available inverse agonist of PPARβ/δ -
C5478 NCT-502Summary: inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH) -
C5557 SR 1824Summary: non-agonist PPARγ ligand -
C5435 G3335Summary: PPARγ antagonist

